phillyrin has been researched along with Alloxan Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, T; Wen, X; Xie, M; Zhang, Z; Zhou, J | 1 |
1 other study(ies) available for phillyrin and Alloxan Diabetes
| Article | Year |
|---|---|
Phillyrin ameliorates diabetic nephropathy through the PI3K/Akt/GSK-3β signalling pathway in streptozotocin-induced diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Glucosides; Glycogen Synthase Kinase 3 beta; Kidney; Male; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation | 2021 |